Korsana Biosciences KRSA
NASDAQ KRSA
$30.49 -0.71 (-2.28%)
At close: Oct 2, 2026 · 4:00 PM EDT

Korsana Biosciences (KRSA) Selling, General & Administrative (2018 - 2025)

Updated

Korsana Biosciences' Selling, General & Administrative came in at $1.53 million for Q3 2025, up 23.5% from $1.24 million a year earlier but down 10.3% from the prior quarter.

Analysis

Korsana Biosciences (KRSA) Selling, General & Administrative (2018 - 2025) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Korsana Biosciences reported Selling, General & Administrative of $5.99 million, up 2.2% year-over-year; for FY2024, it was $5.34 million, down 34.3% from FY2023.

  • Selling, General & Administrative has declined in each of the last five years, with a five-year compound annual growth rate of -31.1% (FY2019 to FY2024).
  • Going back by year, Selling, General & Administrative was $8.13 million in FY2023 (-36.8%), $12.86 million in FY2022 (-37.6%), $20.62 million in FY2021 (-28.4%) and $28.82 million in FY2020 (-16.2%).
  • The five-year range for quarterly Selling, General & Administrative is $1.24 million (Q3 2024) to $7.27 million (Q4 2020).
  • Year-over-year, Selling, General & Administrative increased in two of the last eight quarters, with an average decline of 15.3%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q2 2025 (growth of 33.6%), and the weakest in Q2 2023 (a decline of 56.7%).
  • Business Quant data shows KRSA's Selling, General & Administrative at $1.71 million (Q2 2025), $1.5 million (Q1 2025) and $1.25 million (Q4 2024) in the three quarters before Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Korsana Biosciences 16.10 Mn 1.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.53 Mn
Jun 30, 2025 1.71 Mn
Mar 31, 2025 1.50 Mn
Dec 31, 2024 1.25 Mn
Sep 30, 2024 1.24 Mn
Jun 30, 2024 1.28 Mn
Mar 31, 2024 1.57 Mn
Dec 31, 2023 1.77 Mn
Sep 30, 2023 2.13 Mn
Jun 30, 2023 1.53 Mn
Mar 31, 2023 2.70 Mn
Dec 31, 2022 3.28 Mn
Sep 30, 2022 3.10 Mn
Jun 30, 2022 3.52 Mn
Mar 31, 2022 3.95 Mn
Dec 31, 2021 4.41 Mn
Sep 30, 2021 4.60 Mn
Jun 30, 2021 6.24 Mn
Mar 31, 2021 5.37 Mn
Dec 31, 2020 7.27 Mn
API Access

Korsana Biosciences Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KRSA&period=max&api_key=YOUR_API_KEY